drugset / Trial / NCT06312748

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

NCT06312748

RandomizedCrossoverTriple-blindTreatment

Summary

This project will evaluate the impact of L-Citrulline, tetrahydrobiopterin (BH4), and atorvastatin administration on physical capacity and vascular function in Veterans with heart failure with preserved ejection fraction (HFpEF).

Timeline

Start
2021-05-19
Primary completion
2028-09-30
Completion
2030-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg
Subject L-citrulline Other / unclassified 100 mg
Subject sapropterin Unknown 10 mg/kg